Great to see @DigitalHealth2 covering our work with the @NIHRBioResource!
Our Trusted Research Environment will support research into common and rare diseases while keeping sensitive data in place.
Read more:
digitalhealth.net/2026/09/li…
#HealthData
We're proud to be a Copper sponsor of the @GA4GH 14th Plenary in Singapore next week.
Our team will be there all week to discuss trusted research environments and secure data access.
We look forward to seeing you in Singapore!
ga4gh.org/event/14th-plenary…
#GA4GH #Genomics
Our CEO @mariachatzou speaks at @HumanXCo Europe on how AI understands real-world data, and how in biology and health we get it to understand what we don't yet understand ourselves.
"Engineering the Physical World"
🗓 Thu 24 Sept, 11:35–12:00
📍The Tides, Amsterdam
#HumanX
Lifebit retweeted
We're thrilled to share that @LifebitAI will be exhibiting at The Festival of Genomics and Biodata in London this January! Check out their booth at the UK’s largest life sciences event, register now: hubs.la/Q03SMmgv0 #FOG2026 #genomics #biodata
Lifebit retweeted
A whistleblower says Alphabet’s Verily hid HIPAA breaches impacting 25,000+ patients. The cover-up case is now in court. f-st.co/tZnN62X
We’re live at #BioTechX Europe 2025 in Basel.
📍 Visit us at Stand 662 to meet the Lifebit team, talk data-driven discovery, and see how we’re enabling secure, collaborative research for the future of precision medicine.
#Lifebit #BioTech #PrecisionMedicine #AIinHealthcare
We’re heading to #BioTechX Europe 2025 in Basel next week (6–8 Oct).
Find us at Stand 662 — meet our team, discover how Lifebit powers secure, collaborative data solutions, and grab a coffee while we chat about the future of precision medicine.
#PrecisionMedicine #LifeSciences
Lifebit retweeted
#三井情報 は、英国の Lifebit Biotech Limitedと「Lifebitプラットフォーム」におけるサービスパートナー契約を締結し、2025年7月より提供を開始しました。
mki.co.jp/news/solution/2025…
今後、三井情報はLifebit Biotechと連携のもと、国内のバイオバンク、製薬企業等との協業を推進し、標準化されたバイオメディカルデータ解析基盤を各組織の状況に合わせて柔軟に導入・展開する取り組みを進めます。
これにより、創薬およびライフサイエンス分野における研究開発のさらなる発展と加速を目指します。
#MKI #Lifebit #創薬 #研究開発
We’re live at #GERS2025.
At 14:10 BST, catch our CEO Dr Maria Dunford on the Showcase Stage presenting:
AI in TREs: Harmonised Data, Rapid Target Discovery & Democratised Genomic Insights
@GenomicsEngland
Details: bit.ly/3FF0fP6
24 hours to go until the @GenomicsEngland Research Summit.
We’re looking forward to connecting with leaders in healthcare and life sciences to explore the future of genomic medicine.
Check the full details here: bit.ly/4lcOkHj
#GERS2025
We’re exhibiting at the @GenomicsEngland Research Summit on 17 June!
Join us in London to explore the latest in genomics and how we’re shaping the future of healthcare — from faster diagnoses to personalised treatments.
Register for the event at : genomicsresearchsummit.co.uk
#GERS2025
The #EHDS is here — and Europe needs secure, interoperable TREs to make it work.
We dive into the EOSC-ENTRUST Policy Brief + Lifebit's role in building the future of trusted, federated research infrastructure.
Read more: bit.ly/4j4M97E
#genomics #healthdata #EOSC
🚀 Lifebit’s federated TREs are powering global precision medicine!
A new study names Lifebit in key initiatives, including Genomics England, Singapore’s TRUST, & the Danish National Genome Center.
🔗 Read more: bit.ly/3DwczjB
#Genomics #AI #PrecisionMedicine #Lifebit
How do you turn real-world data into compliant, high-impact data products? Overcome challenges in quality, privacy & compliance.
Learn more: bit.ly/43mHZU3
#RWD #DataProducts #HealthcareTech #Lifebit
🌍💙 Today is #RareDiseaseDay – a day to shine a light on estimated 300M+ people worldwide living with a rare disease. There are over 6,000 rare diseases, but most remain poorly understood and lack effective therapies
Imagine waiting years for a diagnosis—facing endless tests, uncertainty, and, too often, no treatment at all.
🔬 Many rare diseases remain poorly understood and lack effective therapies due to small, fragmented datasets and strict privacy regulations impeding data sharing, which is critical for research.
At Lifebit, our mission is to make biomedical data accessible and actionable wherever it resides. The Lifebit Federated Platform enables researchers to securely analyze genomic data without moving sensitive patient information, so researchers can generate discoveries while protecting privacy. 🧬💡
Because behind every dataset is a person, a family, a life waiting for answers and hope. Let’s push the boundaries of research—together.
#Genomics #FederatedLearning #PrecisionMedicine #RareDiseaseResearch #Lifebit
🌟 New Blog: The Application of Data Lakehouses in Life Sciences 🌟
How can data lakehouses revolutionize life sciences? By harmonizing diverse datasets, fueling AI insights, and future-proofing infrastructure for drug discovery and beyond.
Dive into the blog to explore:
🔹 Key benefits of data lakehouses
🔹 Applications in genomics, clinical trials & precision medicine
🔹 Lifebit’s Trusted Data Lakehouse™ advantage
🔗 bit.ly/4hUHcxM
#DataLakehouse #AI #PrecisionMedicine #DrugDiscovery #Lifebit
How can #Pharma optimize #RealWorldEvidence (RWE) to accelerate drug discovery and improve patient outcomes?
Our latest blog dives into the key challenges, strategies, and technologies driving the future of RWE.
Read more: bit.ly/4i4fVJ1
#ClinicalTrials #LifeSciences #DrugDiscovery
Lifebit retweeted
Great piece on our key partnership with the @23andMe led @LCGeneticsStudy to drive #LungCancer #Research on @lifebitAI’s #TrustedResearchEnvironment #TRE
pharmaceuticalmanufacturer.m…
Lifebit retweeted
Great piece on our key partnership with @CR_Horizons to maximise the impact of data generated through @CR_UK via the @lifebitAI Federated Data Network & #TrustedResearchEnvironment #genomics #rwd #cancerresearch #Oncology
ddw-online.com/partnership-w…
Lifebit retweeted
Fantastic to see the next step in the @LCGeneticsStudy. They've teamed up with @lifebitAI to build a new secure platform to help analyse data from 10,000 lung cancer patients by 2027.
If you've been diagnosed with lung cancer, you can help too!
More at👇
einnews.com/pr_news/78463707…



















